RATIOS
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 06
3431.50
-28.20 ( -0.82%)
Volume
5384
Prev. Close
3459.70
Open Price
3458.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
3438.50
-27.70 ( -0.80%)
Volume
149126
Prev. Close
3466.20
Open Price
3451.10
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
58250.26
|
P/BV
|
34.82
|
Book Value ( ₹ )
|
98.74
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3516/1921
|
FV/ML
|
10/1
|
P/E(X)
|
62.80
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.57
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 54.01 | 40.83 | 35.90 | 99.05 | 31.32 |
Diluted EPS (Rs.) | 54.24 | 34.51 | 35.88 | 99.79 | 21.11 |
Cash EPS (Rs.) | 58.19 | 38.63 | 39.76 | 103.82 | 25.75 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 115.06 | 105.31 | 103.48 | 158.06 | 88.37 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 115.06 | 105.31 | 103.48 | 158.06 | 88.37 |
Dividend / Share (Rs.) | 54.00 | 32.00 | 32.00 | 90.00 | 30.00 |
Revenue From Operations / Share (Rs.) | 219.79 | 201.13 | 189.86 | 189.93 | 172.40 |
PBDIT / Share (Rs.) | 77.44 | 60.45 | 53.18 | 49.12 | 41.79 |
PBIT / Share (Rs.) | 73.49 | 56.34 | 49.30 | 45.09 | 37.15 |
PBT / Share (Rs.) | 73.69 | 47.76 | 49.13 | 45.66 | 26.75 |
Net Profit / Share (Rs.) | 54.25 | 34.51 | 35.88 | 99.79 | 21.11 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 35.23 | 30.05 | 28.01 | 25.85 | 24.24 |
PBIT Margin (%) | 33.43 | 28.01 | 25.96 | 23.74 | 21.54 |
PBT Margin (%) | 33.52 | 23.74 | 25.88 | 24.03 | 15.51 |
Net Profit Margin (%) | 24.68 | 17.16 | 18.89 | 52.54 | 12.24 |
Return on Networth / Equity (%) | 47.14 | 32.77 | 34.66 | 63.13 | 23.88 |
Return on Capital Employeed (%) | 56.59 | 46.85 | 41.53 | 25.90 | 35.40 |
Return On Assets (%) | 22.41 | 16.48 | 18.26 | 36.57 | 11.54 |
Asset Turnover Ratio (%) | 0.97 | 0.99 | 0.80 | 0.83 | 0.93 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.78 | 1.83 | 1.87 | 2.19 | 1.65 |
Quick Ratio (X) | 1.54 | 1.49 | 1.54 | 1.89 | 1.25 |
Inventory Turnover Ratio (X) | 0.96 | 1.06 | 0.82 | 1.07 | 0.89 |
Dividend Payout Ratio (NP) (%) | 0.00 | 92.71 | 250.86 | 30.06 | 189.50 |
Dividend Payout Ratio (CP) (%) | 0.00 | 82.84 | 226.37 | 28.89 | 155.35 |
Earning Retention Ratio (%) | 0.00 | 7.29 | -150.86 | 69.94 | -89.50 |
Cash Earning Retention Ratio (%) | 0.00 | 17.16 | -126.37 | 71.11 | -55.35 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 1001.41 | 569.37 | 497.54 | 418.15 | 200.48 |
Interest Coverage Ratio (Post Tax) (%) | 698.99 | 405.91 | 335.48 | 184.43 | 131.06 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 47343.45 | 31856.08 | 21281.16 | 25692.26 | 23243.59 |
EV / Net Operating Revenue (X) | 12.71 | 9.35 | 6.62 | 7.99 | 7.96 |
EV / EBITDA (X) | 36.09 | 31.11 | 23.62 | 30.88 | 32.83 |
MarketCap / Net Operating Revenue (X) | 13.09 | 9.66 | 6.97 | 8.76 | 8.36 |
Retention Ratios (%) | 0.00 | 7.28 | -150.86 | 69.93 | -89.50 |
Price / BV (X) | 25.01 | 18.45 | 12.80 | 10.52 | 16.30 |
Price / Net Operating Revenue (X) | 13.09 | 9.66 | 6.97 | 8.76 | 8.36 |
EarningsYield | 0.01 | 0.01 | 0.02 | 0.06 | 0.01 |